No. Check for tolerance first. Responsiveness does not equal need, nor benefit. Maximizing output was shown decades ago to not be a viable strategy. Optimize tissue perfusion. Learners, please reconsider a forward-flow-centric approach. Focus on tissue perfusion, and the two do NOT have a linear relationship. Understand hemodynamic interfaces. Ping @icmteaching@khaycock2@EMNerd_@edu_kattan@ross_prager
Dynamic indices of fluid responsiveness in @ICM
w/ @Prof_XMonnet@MichelleChew
💧Physiology of fluid responsiveness
📈Tests to predict fluid responsiveness
⚠️Clinical limits of these tests
Check for potential benefits before giving #fluids!
🔗rdcu.be/fnlTm#FOAM
SODa-BIC just dropped in NEJM. The large, rigorous RCT examining the use of sodium bicarbonate ICU patients with shock and acidosis.
nejm.org/doi/full/10.1056/NE…
Three placebo-controlled trials. Bicarb corrects the pH. It does not improve hemodynamics, reduce mortality, or protect kidneys. The RRT signal is clinicians using the dialysis circuit as a substitute buffer drip.
30 mL/kg has never been supported by evidence and physiologically it is nonsensical to think a weight-based prescription would be beneficial. Assess the hemodynamics in front of you and treat accordingly
The ARISE FLUIDS trial was just published in the NEJM examining early IV fluids vs early vasopressors in septic shock. Just a reminder, fluids aren't the cure for sepsis
nejm.org/doi/full/10.1056/NE…
The vasopressor group received just 7 mL/kg in the first 6 hours of resuscitation and outcomes were identical. Because IV fluids are not the cure for sepsis!
30 mL/kg has never been supported by evidence and physiologically it is nonsensical to think a weight-based prescription would be beneficial. Assess the hemodynamics in front of you and treat accordingly
my 2 cents on this:
1) agree w Rory
2) nonetheless, I still target 130-150. It’s impossible to fight guidelines here. This is an *improvement* to prior [disasterous] recs to target “SBP<140”
3) clevidipine would likely avoid overshoot (more intuitive to use than nicardipine)
1/A new study by Shi et al. (Ann Emerg Med 2026) questions the current AHA blood pressure recommendations for intracerebral hemorrhage.
pubmed.ncbi.nlm.nih.gov/4136…
1/A new study by Shi et al. (Ann Emerg Med 2026) questions the current AHA blood pressure recommendations for intracerebral hemorrhage.
pubmed.ncbi.nlm.nih.gov/4136…
4/ Nicardipine infusions overshot just as often as bolus dosing (55% vs 46%). When goal BP was achieved early without overshooting, outcomes were no different than never hitting goal at all.
5/ The retrospective design limits how certain we can be of this signal of harm. But consider INTERACT-2 and ATACH-2 found no meaningful benefit and this cohort showed what happens when these targets are actually implemented in the real-world and the potential harms associated.